8-K - Artiva Biotherapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Artiva Biotherapeutics, Inc. filed an 8-K on March 10, 2026, under Item 2.02 disclosing results of operations via Exhibit 99.1 Press Release, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Item 9.01 lists the exhibits including the press release.

Key Takeaways

1Item 2.02 triggered for results of operations disclosure.

2Exhibit 99.1 is Press Release dated March 10, 2026.

3Exhibit 104 is Cover Page Interactive Data File.

4Disclosure under Item 2.02 not deemed 'filed' under Section 18.

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 10, 2026. 104 Cover Page Interactive Data File (embedde

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1